| name | ata-ppgl-bone-metastasis-management |
| description | This skill guides management of bone metastases in pheochromocytoma and paraganglioma, recommending external radiation therapy and surgical approaches similar to other solid cancers. It is triggered by known or suspected bone metastases, spinal cord compression symptoms, bone pain, pathological fracture, or hypercalcemia in a PPGL patient, emphasizing prompt diagnosis/treatment for spinal cord compression and consideration of bone-modifying agents for skeletal-related event prevention. |
Manage bone metastases in pheochromocytoma and paraganglioma
STEP 1 — Gather Information
Collect imaging confirming bone metastases (bone scan, MRI, CT, or PET), assess for spinal cord compression symptoms (progressive back pain, neurologic deficit, bowel/bladder dysfunction), check serum calcium, alkaline phosphatase, and performance status; then proceed to evaluate for spinal cord compression.
STEP 2 — Rule In / Rule Out
Determine if spinal cord compression symptoms are present: if yes, proceed to urgent MRI and high-dose steroids; if no, assess for other skeletal-related events (pain, fracture, hypercalcemia) and proceed to classification.
STEP 3 — Classify or Stratify
Classify bone metastasis by location (spine vs. non-spine) and stability (mechanically unstable vs. stable) based on imaging; if unstable spine or neurologic deficit, proceed to urgent intervention; if stable, proceed to decide on local therapy and bone-modifying agents.
STEP 4 — Decide
For spinal cord compression: administer high-dose dexamethasone and obtain urgent MRI; if confirmed, recommend external beam radiation therapy (± surgery) similar to solid cancers; for stable bone metastases: offer external radiation therapy or surgical stabilization; consider bone-modifying agents (e.g., zoledronic acid, denosumab) for skeletal-related event prevention regardless of location.
Clinical Guardrails / Mimics / Pitfalls
Do not delay imaging or steroids for suspected spinal cord compression; avoid bone-modifying agents as sole treatment for mechanically unstable lesions; do not use NSAIDs as primary analgesic in hypertensive PPGL without alpha-blockade; avoid external radiation without prior alpha-blockade if catecholamine excess is uncontrolled.
Concrete Clinical Example
A 58-year-old with known SDHB-mutated PPGL presents with worsening thoracic back pain and leg weakness. MRI shows T8 vertebral body metastasis with epidural cord compression. After dexamethasone and alpha-blockade, urgent SBRT to 24 Gy in 2 fractions is performed; zoledronic acid is started post-radiation for SRE prevention.
Source: Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025, Japan Endocrine Society, 2025, doi:10.1507/endocrj.EJ25-0165
